LIFR expression has further been proposed as a biomarker for the differentiation of HCC from dysplastic nodules, showing that LIFR expression decreases as the tumor cells progress from low-grade dysplastic nodules to HCC [94]. Here, LIFR is linked to hepatocellular carcinoma.